Home › Therapeutic areas › Oncology › Neurofibromatosis Type 1
Neurofibromatosis Type 1 (1 companies)
Companies with an active program in Neurofibromatosis Type 1.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| KTTA | Pasithea Therapeutics | NeurologyOncology Rare | 1 | Phase 1 | $19.3M | 4 |
No companies match.